Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Elisavet Kaldara"'
Autor:
Magdalini Migkou, Constantinos Pamboucas, Argyrios Ntalianis, Evangelos Terpos, Maria Roussou, Meletios A. Dimopoulos, Despina Kalapanida, Efstathios Kastritis, Maria Gavriatopoulou, Savvas Toumanidis, Elisavet Kaldara, Anna Tasidou, Erasmia Psimenou
Publikováno v:
American Journal of Hematology. 90:E60-E65
Bortezomib and lenalidomide are increasingly used in patients with AL amyloidosis, but long term data on their use as primary therapy in AL amyloidosis are lacking while early mortality remains significant. Thus, we analyzed the long term outcomes of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9683a104504bdd4e23b23c9e15f85fd4
https://doi.org/10.1002/ajh.23936
https://doi.org/10.1002/ajh.23936
Autor:
Elisavet Kaldara, Theodoros Pitsolis, Michael Koutsilieris, Georgios Tzanis, Anastassios Philippou, Eleftherios Karatzanos, Dimitra Rontogianni, Emmeleia Nana, Stavros Dimopoulos, Serafim Nanas
Publikováno v:
Journal of cardiac failure. 23(1)
Background It remains controversial which type of exercise elicits optimum adaptations on skeletal myopathy of heart failure (HF). Our aim was to evaluate the effect of high-intensity interval training (HIIT), with or without the addition of strength
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8960535f66ac1c13edc73a995121cd51
https://pubmed.ncbi.nlm.nih.gov/27327970
https://pubmed.ncbi.nlm.nih.gov/27327970
Autor:
Efstathios, Kastritis, Maria, Roussou, Maria, Gavriatopoulou, Magdalini, Migkou, Despina, Kalapanida, Constantinos, Pamboucas, Elisavet, Kaldara, Argyrios, Ntalianis, Erasmia, Psimenou, Savvas T, Toumanidis, Anna, Tasidou, Evangelos, Terpos, Meletios A, Dimopoulos
Publikováno v:
American journal of hematology. 90(4)
Bortezomib and lenalidomide are increasingly used in patients with AL amyloidosis, but long term data on their use as primary therapy in AL amyloidosis are lacking while early mortality remains significant. Thus, we analyzed the long term outcomes of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0aa1dccac0ab72048035631e17e3b1bf
https://pubmed.ncbi.nlm.nih.gov/25580702
https://pubmed.ncbi.nlm.nih.gov/25580702
Autor:
Eleni Tseliou, Elisavet Kaldara, S Dimopoulos, Varvara Agapitou, Athanasios Tasoulis, Iraklis Pozios, John Terrovitis, Serafim Nanas, Christos Manetos, Lampros Samartzis
Publikováno v:
World journal of cardiology. 6(10)
To evaluate Quality of life (QoL) in chronic heart failure (CHF) in relation to Neuroticism personality trait and CHF severity.Thirty six consecutive, outpatients with Chronic Heart Failure (6 females and 30 males, mean age: 54 ± 12 years), with a l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea32cf7d387635ee4ebb8f6a06d55bf7
https://pubmed.ncbi.nlm.nih.gov/25349656
https://pubmed.ncbi.nlm.nih.gov/25349656
Publikováno v:
Expert review of cardiovascular therapy. 9(9)
Volume overload is a common manifestation of heart failure decompensation. Interaction between impaired renal and heart function constitutes an important pathophysiologic mechanism that leads to congestion. In addition to improving symptoms and volum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05df1fe453792f66f7f3d670c8f63458
https://pubmed.ncbi.nlm.nih.gov/21932961
https://pubmed.ncbi.nlm.nih.gov/21932961
Autor:
Eleftheria P Tsagalou, Maria Anastasiou-Nana, Argyrios Ntalianis, Nikolaos Lazaris, Michail Bonios, Elisavet Kaldara, Eleni Tseliou, Fotis Katsaros, John Nanas
Publikováno v:
Circulation. 118
Background: Levosimendan, a novel inodilator, has been shown to improve hemodynamic function in patients with decompensated heart failure with preserved arterial blood pressure. Data on its use in patients with cardiogenic shock are scarce. The prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::955a1f2ed4d3267b19a1d242b7ca39ca
https://doi.org/10.1161/circ.118.suppl_18.s_657-d
https://doi.org/10.1161/circ.118.suppl_18.s_657-d
Autor:
Efstathios Kastritis, Ioannis Boletis, Evangelos Terpos, Maria Gavriatopoulou, Evangelos Kostis, Sofoklis Kontogiannis, Maria Roussou, Meletios A. Dimopoulos, Evangelos Eleutherakis-Papaiakovou, Filia Apostolakou, Constantinos Pamboucas, Savvas Toumanidis, Elisavet Kaldara, Ioannis Papassotiriou, Athanassios Akalestos, Erasmia Psimenou, Despoina Kalapanida
Publikováno v:
Blood. 124:306-306
Growth differentiation factor-15 (GDF-15) is a member of the TGF-beta family, which is involved in several pathological conditions, including inflammation, cancer, cardiovascular, pulmonary and renal diseases. GDF-15 has prognostic value in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84a2413453c9ee05ac50ccfd53765694
https://doi.org/10.1182/blood.v124.21.306.306
https://doi.org/10.1182/blood.v124.21.306.306
Autor:
Maria Roussou, Efstathios Kastritis, Evangelos Terpos, Constantinos Pamboukas, Meletios A. Dimopoulos, Maria Gavriatopoulou, Savvas Toumanidis, Magdalini Migkou, Argirios Dalianis, Alexandra Gkougkoutsi, Elisavet Kaldara, Erasmia Psimenou
Publikováno v:
Blood. 120:1786-1786
Abstract 1786 Novel antimyeloma agents (thalidomide, lenalidomide and bortezomib) may induce high rates of hematologic responses in patients with AL amyloidosis in whom they are increasingly used. Due to the multisystemic involvement many patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8391f99a3b6bba90dbc74054f30cad5f
https://doi.org/10.1182/blood.v120.21.1786.1786
https://doi.org/10.1182/blood.v120.21.1786.1786
Autor:
Dimitrios A. Kontoyannis, Evangelos Repasos, Elisavet Kaldara, Christos Kapelios, John Terrovitis, Argyrios Ntalianis, Styliani Vakrou, Michael J. Bonios, John Kanakakis, John N. Nanas, Panagiotis Siskas
Publikováno v:
Journal of the American College of Cardiology. 59:E931
Despite maximal therapy, patients with advanced heart failure frequently experience continuous deterioration, while end organ dysfunction precludes long term mechanical support (LVAD) or transplantation. We examined the role of long term IABP support
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bfc409c6a217bc9c5e45a2ac6b5e88
https://doi.org/10.1016/s0735-1097(12)60932-2
https://doi.org/10.1016/s0735-1097(12)60932-2
Autor:
George Sainis, Vassilios Sousonis, Nickolaos Michelinakis, Christos Kapelios, John Terrovitis, Stefania Sventzouri, John N. Nanas, Argyrios Ntalianis, Zafeiria Margari, Elisavet Kaldara
Publikováno v:
Journal of the American College of Cardiology. (13):E886
Diuretics relieve congestion in HF patients but activate the renin-angiotensin-aldosterone system (RAAS). High furosemide doses have been correlated with higher mortality; it is not clear whether higher diuretic doses represent a marker of disease se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3c810fbe12b15745989dccfb921c933